MADOPAR HBS IN PARKINSONIAN-PATIENTS PRESENTING MARKED FLUCTUATIONS IN SYMPTOMS ON STANDARD L-DOPA TREATMENT

被引：0
|
作者：
JENSEN, NO
DUPONT, E
HANSEN, E
MIKKELSEN, B
MIKKELSEN, BO
机构：
[1] UNIV HOSP HVIDORE,DEPT NEUROL,HVIDORE,DENMARK
[2] AARHUS UNIV HOSP,DEPT NEUROL,DK-8000 AARHUS C,DENMARK
[3] ODENSE UNIV HOSP,DEPT NEUROL,DK-5000 ODENSE,DENMARK
[4] HJORRING HOSP,DEPT NEUROL,HJORRING,DENMARK
[5] ROCHE AS,DEPT CLIN RES,HVIDOVRE,DENMARK
来源：
UPSALA JOURNAL OF MEDICAL SCIENCES | 1986年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] LONG-TERM TREATMENT WITH MADOPAR HBS IN PARKINSONIAN-PATIENTS WITH FLUCTUATIONS AND IN DENOVO PATIENTS
    CHOUZA, C
    ALJANATI, R
    CAAMANO, JL
    DEMEDINA, O
    PLACHIN, V
    SCARAMELLI, A
    ROMERO, S
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1988, 77 : 132 - 132
  • [2] L-DOPA AND THE SECRETION OF SEBUM IN PARKINSONIAN-PATIENTS
    STREIFLER, M
    AVRAMI, E
    RABEY, JM
    [J]. EUROPEAN NEUROLOGY, 1980, 19 (01) : 43 - 48
  • [3] CLINICAL EFFECTIVENESS OF MADOPAR-HBS IN PARKINSONIAN-PATIENTS WITH FLUCTUATIONS IN MOTOR-PERFORMANCE
    PETROVA, T
    GEORGIEV, D
    HADJIEV, D
    MILANOV, I
    [J]. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 1994, 18 (02) : 136 - 137
  • [4] MADOPAR HBS IN FLUCTUATING PARKINSONIAN-PATIENTS - 2-YEAR TREATMENT
    PEZZOLI, G
    TESEI, S
    FERRANTE, C
    COSSUTTA, E
    ZECCHINELLI, A
    SCARLATO, G
    [J]. MOVEMENT DISORDERS, 1988, 3 (01) : 37 - 45
  • [5] DOPAMINE L-DOPA RATIO IN CEREBROSPINAL-FLUID OF PARKINSONIAN-PATIENTS TREATED WITH L-DOPA + BENSERAZIDE
    FEKETE, M
    TARCZY, M
    BIHARI, K
    KATONA, G
    [J]. PSYCHOPHARMACOLOGY, 1984, 82 (1-2) : 93 - 94
  • [6] A CONTROLLED RELEASE FORM OF MADOPAR IN PARKINSONIAN-PATIENTS WITH ADVANCED DISEASE AND MARKED FLUCTUATIONS IN MOTOR-PERFORMANCE
    JENSEN, NO
    DUPONT, E
    HANSEN, E
    MIKKELSEN, B
    MIKKELSEN, BO
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1988, 77 (05): : 422 - 425
  • [7] ELECTRORETINOGRAMS AND VISUAL EVOKED CORTICAL POTENTIALS IN PARKINSONIAN-PATIENTS WITH OR WITHOUT L-DOPA TREATMENT
    GELMI, C
    SANDRINI, G
    MARTIGNONI, E
    BRUNO, A
    NAPPI, G
    TRIMARCHI, F
    [J]. NEURO-OPHTHALMOLOGY, 1992, 12 (02) : 125 - 132
  • [8] PERIPHERAL L-DOPA PHARMACOKINETICS IN UNTREATED, STABLE, AND FLUCTUATING PARKINSONIAN-PATIENTS
    GANCHER, ST
    NUTT, JG
    WOODWARD, W
    [J]. NEUROLOGY, 1986, 36 (04) : 216 - 216
  • [9] LACK OF LENGTHENING OF L-DOPA EFFECT BY DEPRENYL (SELEGILINE) IN PARKINSONIAN-PATIENTS
    RASCOL, O
    SENARD, JM
    SIMONETTA, M
    DEMONET, JF
    MONTASTRUC, JL
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1988, 2 (02) : 130 - 130
  • [10] MENTAL SYMPTOMS IN PARKINSONIAN PATIENTS TREATED WITH L-DOPA
    HERSON, RN
    [J]. LANCET, 1970, 2 (7675): : 721 - &
12345